Melatonin in chronic kidney disease: a promising chronotherapy targeting the intrarenal renin-angiotensin system

Hypertens Res. 2019 Jun;42(6):920-923. doi: 10.1038/s41440-019-0223-9. Epub 2019 Feb 13.

Authors

Asadur Rahman¹, Arif Ul Hasan¹, Hiroyuki Kobori²

Affiliations

¹ Department of Pharmacology, School of Medicine, International University of Health and Welfare, 4-2 Kozunomori, Narita, Chiba, 286-8686, Japan.
² Department of Pharmacology, School of Medicine, International University of Health and Welfare, 4-2 Kozunomori, Narita, Chiba, 286-8686, Japan. hkobori@iuhw.ac.jp.

PMID: 30760889
DOI: 10.1038/s41440-019-0223-9

No abstract available

Publication types

Editorial

MeSH terms

Animals
Antioxidants / therapeutic use*
Chronotherapy / methods*
Humans
Kidney / drug effects*
Melatonin / therapeutic use*
Renal Insufficiency, Chronic / drug therapy*
Renin-Angiotensin System / drug effects*

Substances

Antioxidants
Melatonin

Grants and funding

R01 DK072408/DK/NIDDK NIH HHS/United States